Synonyms: 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-; cinchonidine; L-Cinchonidine; BRD-K17661460-001-03-2; BRD-K17661460-001-04-0; BRD-K39079086-001-05-0; BRD-K39079086-001-07-6; Cinchonidine, purum, >=98.0% (dried material, NT); (R)-4-quinolyl-[(2S,4S,5R)-5-vinylquinuclidin-2-yl]methanol; (-)-Cinchonidine, 99% (total base), may cont. up to 5% quinine; (1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (2S,4S,8R,alphaR)-alpha-(4-Quinolyl)-8-vinyl-1-azabicyclo[2.2.2]octane-2-methanol; (8S,9R)-Cinchonidine; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-quinolin-4-ylmethanol; cinchonine; Cinchonidine hydrochloride; cinchonidine sulfate(2:1); Cinchonidine monohydrochloride; C19H22N2O; NSC5364; AR-1H7522; C19-H22-N2-O; alpha-Quinidine; CID101744; ACN-048721; CB10504; Cinchonidine, 98.5% - 25G 25g; Ethyl 5-nitroisothiazole-3-carboxylate; A10220; C041622; cinchonidine, (1beta,3alpha,4beta,8alpha,9R)-isomer; (-)-Cinchonidine, 99%, may contain up to 5% quinine 25g; (4S,5R,7S)-(-)-7-((R)-(4-Chinolinyl)(hydroxy)methyl)-5-ethenylazabicyclo[2.2.2]octan; UNII-1U622LRA8Z; (R)-[(4S,5R,7S)-5-Ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-quinolin-4-ylmethanol; 5112-42-5; TCMDC-123934; MFCD00006783; (8S,9R)-cinchonan-9-ol; a-quinidine; (8alpha,9R)-Cinchonan-9-ol; 1U622LRA8Z; cinchonidine hydrochloride; CHEBI:3703; Cinchonan-9-ol, (8a,9R)-; (8-alpha,9R)-Cinchonan-9-ol; (8alpha,9R)Cinchonan-9-ol; NSC 5364; 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-; EINECS 207-622-3; Cinchonan-9-ol, (8.alpha.,9R)-; (R)-[(4S,5S,7S)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-quinolin-4-ylmethanol; AI3-15317; cinchonidine monohydrochloride; SR-05000001575; Cinchonan-9-ol, (8alpha,9R)-; Cinchonan-9-ol, (8a alpha,9R)-; (-)cinchonidine; (-) cinchonidine; Cinchonidine,(S); Prestwick_66; Cinchonidine, 96%; PubChem7953; Spectrum_001165; cinchonidine sulfate(2:1); AC1L2RGN; Prestwick3_000606; Spectrum2_000719; Spectrum3_001745; Spectrum4_001173; Spectrum5_002073; AC1Q4XW3; BSPBio_000512; BSPBio_003450; KBioGR_001805; cinchonidine, (1beta,3alpha,4beta,8alpha,9R)-isomer; KBioSS_001645; MLS002153905; DivK1c_000501; SCHEMBL159532; SPECTRUM1500839; SPBio_000937; BPBio1_000564; CHEMBL533841; HMS501J03; KBio1_000501; CINCHONIDINE; KBio2_001645; KBio2_004213; KBio2_006781; KBio3_002670; KMPWYEUPVWOPIM-KODHJQJWSA-N; NINDS_000501; HMS1921K14; HMS2092M14; HMS2096J14; HMS2235F22; (-)-Cinchonidine; Pharmakon1600-01500839; ZINC155697; 485-70-1; HY-N0173; STR04708; ZX-AT015805; CCG-36455; CCG-37735; NSC757800; OR2776; 485-71-2; (-)-Cinchonidine, analytical standard; AKOS016008633; API0002019; NSC-757800; SDCCGMLS-0066969.P001; IDI1_000501; NCGC00178057-01; NCGC00178057-02; SMR001233254; SBI-0051617.P002; Cinchovatine; AB0019836; Cinchonan-9-ol, (8-alpha,9R)- (9CI); CS-0007887; ST24030253; V0360; AB00052182_03; SR-05000001575-1; SR-05000001575-6; SR-05000001575-7; SR-05000001575-8;